Thermo Fisher Scientific, Inc. Stock
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 624.65 USD | +0.45% |
|
+2.99% | +7.80% |
| 01-15 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 01-13 | Thermo Fisher wins contracts as pharma shifts production to US, CEO says | RE |
| Capitalization | 235B 202B 188B 175B 326B 21,204B 350B 2,165B 852B 10,137B 880B 862B 37,188B | P/E ratio 2025 * |
35x | P/E ratio 2026 * | 31.5x |
|---|---|---|---|---|---|
| Enterprise value | 263B 227B 211B 196B 365B 23,760B 392B 2,426B 954B 11,359B 986B 966B 41,671B | EV / Sales 2025 * |
5.94x | EV / Sales 2026 * | 5.55x |
| Free-Float |
86.06% | Yield 2025 * |
0.27% | Yield 2026 * | 0.28% |
Last Transcript: Thermo Fisher Scientific, Inc.
| 1 day | +0.45% | ||
| 1 week | +2.99% | ||
| Current month | +7.80% | ||
| 1 month | +8.46% | ||
| 3 months | +18.33% | ||
| 6 months | +49.44% | ||
| Current year | +7.80% |
| 1 week | 594.3 |  | 629.87 |
| 1 month | 554.53 | | 629.87 |
| Current year | 577 | | 629.87 |
| 1 year | 385.46 | | 629.87 |
| 3 years | 385.46 | | 629.87 |
| 5 years | 385.46 | | 672.34 |
| 10 years | 119.75 | | 672.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 58 | 15/10/2009 |
| Director of Finance/CFO | 59 | 01/08/2015 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 68 | 09/11/2006 |
Marc Casper
CHM | Chairman | 58 | 26/02/2020 |
Tyler Jacks
BRD | Director/Board Member | 65 | 26/05/2009 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.50% | 7.43% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.45% | +2.99% | +13.27% | +6.99% | 235B | |
| -0.99% | -7.48% | -6.68% | +109.09% | 192B | |
| +0.82% | +2.08% | +0.81% | -12.33% | 169B | |
| -3.96% | -8.49% | -7.08% | +93.49% | 133B | |
| -0.53% | +0.58% | -9.16% | -6.06% | 60.62B | |
| +1.67% | -0.11% | +20.22% | +7.89% | 49.03B | |
| -0.75% | -0.64% | +1.83% | -7.70% | 41.06B | |
| -3.27% | -6.41% | -1.37% | +26.08% | 37.59B | |
| +0.46% | +3.90% | +11.71% | +19.53% | 37.97B | |
| -1.77% | +1.17% | -13.16% | -38.31% | 35.43B | |
| Average | -0.87% | -1.34% | +1.04% | +19.87% | 99.12B | |
| Weighted average by Cap. | -0.77% | -1.61% | +1.47% | +33.33% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 44.28B 38.14B 35.54B 33.07B 61.52B 4,000B 65.99B 408B 161B 1,912B 166B 163B 7,016B | 46.57B 40.11B 37.38B 34.78B 64.7B 4,208B 69.41B 430B 169B 2,011B 175B 171B 7,379B |
| Net income | 6.72B 5.79B 5.39B 5.02B 9.33B 607B 10.01B 61.96B 24.38B 290B 25.19B 24.67B 1,064B | 7.39B 6.36B 5.93B 5.52B 10.26B 667B 11.01B 68.14B 26.81B 319B 27.7B 27.13B 1,171B |
| Net Debt | 28.29B 24.37B 22.71B 21.12B 39.3B 2,556B 42.16B 261B 103B 1,222B 106B 104B 4,482B | 23.96B 20.64B 19.23B 17.89B 33.29B 2,165B 35.71B 221B 86.96B 1,035B 89.84B 88B 3,797B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/01/26 | 624.65 $ | +0.45% | 2,541,472 |
| 14/01/26 | 621.83 $ | +2.43% | 2,460,459 |
| 13/01/26 | 607.08 $ | -1.36% | 2,847,779 |
| 12/01/26 | 615.45 $ | -0.55% | 3,184,763 |
| 09/01/26 | 618.86 $ | +2.04% | 2,286,520 |
Delayed Quote Nyse, January 16, 2026 at 01:00 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition